Evidence map›Paper›PMID 36074890›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Next-Generation Sequencing Supports Targeted Antibiotic Treatment for Culture Negative Orthopedic Infections.

Ravina Kullar, Emanuele Chisari, James Snyder, Christopher Cooper, Javad Parvizi, Jason Sniffen

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06670885 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Innovative Molecular Approaches for the Diagnosis of Prosthetic Joint Infections

TypeobservationalSponsorI.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRan2024 to 2027Enrolled70ConditionsProsthetic Joint Infection
NCT06791993 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Impact of Probiotics Combined with Antibiotic Prophylaxis on Gut Microbiome Balance in Patients Undergoing Elective Orthopedic Surgery, Double-Blinded Randomized Controlled Trial

TypeinterventionalSponsorAcibadem Maslak HospitalRan2025 to 2025Enrolled60ConditionsDysbiosis, Gut -microbiota, Microbiome Analysis, ProbioticArmsPlacebo Capsule, Probiotic with Human Milk Oligosaccharides (HMO)
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ravina KullarExpert Stewardship, Inc., Newport Beach, California, USA.
Emanuele ChisariAntimicrobial Stewardship & Infection Prevention, Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
James SnyderDepartment of Pathology and Laboratory Medicine, University of Louisville School of Medicine and Hospital, Louisville, Kentucky, USA.
Christopher CooperDepartment of Internal Medicine, Infectious Diseases and Tropical Medicine Section, University of South Florida, Tampa, Florida, USA.
Javad ParviziAntimicrobial Stewardship & Infection Prevention, Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jason SniffenDepartment of Internal Medicine, Infectious Diseases and Tropical Medicine Section, University of South Florida, Tampa, Florida, USA.ORCID 0000-0002-6858-7990
Thomas Jefferson University · USUniversity of South Florida · USUniversity of Louisville Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The isolation of an infective pathogen can be challenging in some patients with active, clinically apparent infectious diseases. Despite efforts in the microbiology lab to improve the sensitivity of culture in orthopedic implant-associated infections, the clinically relevant information often falls short of expectations. The management of peri-prosthetic joint infections (PJI) provides an excellent example of the use and benefits of newer diagnostic technologies to supplement the often-inadequate yield of traditional culture methods as a substantial percentage of orthopedic infections are culture-negative. Next-generation sequencing (NGS) has the potential to improve upon this yield. Bringing molecular diagnostics into practice can provide critical information about the nature of the infective organisms and allow targeted therapy in these otherwise challenging situations. This review article describes the current state of knowledge related to the use and potential of NGS to diagnose infections, particularly in the setting of PJIs.

Indexed as

Arthritis, InfectiousProsthesis-Related InfectionsAnti-Bacterial AgentsHigh-Throughput Nucleotide SequencingHumansProstheses and ImplantsAnti-Bacterial Agentsantibiotic stewardshipclinical microbiologymetagenomicsnext-generation sequencingorthopedic infections

Identifiers

PMID36074890
PMCPMC9839185
OpenAlexW4295079695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.